Inventor · disambiguated record
Erik Meredith
Also filed as: MEREDITH ERIK · MEREDITH ERIK LEE
18 granted patents·6 pending applications·91 citations·filing 2006–2024
91Inventor score
Files withARTMAN III GERALD DAVID6KSANDER GARY MICHAEL4ADAMS CHRISTOPHER M3ADAMS CHRISTOPHER MICHAEL2CASMA THERAPEUTICS INC2
Top patents by PatentIndex Score
24 records- 0196US8501756B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Aug 6, 2013·65 cites·3 claims
- 0290US8609862B2Use of an adrenal hormone-modifying agentHU QI-YING·Filed 2011·Granted Dec 17, 2013·8 cites·5 claims
- 0387US8314097B2Organic compoundsKSANDER GARY MICHAEL·Filed 2006·Granted Nov 20, 2012·10 cites·6 claims
- 0480US8242125B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2009·Granted Aug 14, 2012·3 cites·19 claims
- 0579US8835646B2Organic compoundsKSANDER GARY MICHAEL·Filed 2013·Granted Sep 16, 2014·3 cites·8 claims
- 0674US12129246B1Hydroquinazoline derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Granted Oct 29, 2024·0 cites·30 claims
- 0774US8846656B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2012·Granted Sep 30, 2014·2 cites·3 claims
- 0867US9434754B2Use of an adrenal hormone-modifying agentHU QI-YING·Filed 2013·Granted Sep 6, 2016·0 cites·1 claims
- 0962US8541432B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Sep 24, 2013·0 cites·3 claims
- 1062US8492393B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Jul 23, 2013·0 cites·6 claims
- 1162US8486954B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Jul 16, 2013·0 cites·3 claims
- 1262US8431584B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Apr 30, 2013·0 cites·6 claims
- 1361US9278969B2Organic compoundsKSANDER GARY MICHAEL·Filed 2014·Granted Mar 8, 2016·0 cites·4 claims
- 1455US2012277215A1Organic CompoundsKSANDER GARY MICHAEL·Filed 2012·Application pending·0 cites
- 1553US9505755B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Nov 29, 2016·0 cites·11 claims
- 1653US2023416262A1Trpml modulatorsCASMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1752US10550102B2Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activatorsNOVARTIS AG·Filed 2018·Granted Feb 4, 2020·0 cites·15 claims
- 1850US2023104936A1Trpml modulatorsCASMA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1950US2011092505A1Organic compoundsBURGIS ROBIN·Filed 2009·Application pending·0 cites
- 2046US2012142685A1Organic compoundsDOBLER MARKUS ROLF·Filed 2008·Application pending·0 cites
- 2145US10208018B2Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Feb 19, 2019·0 cites·18 claims
- 2232US9765067B2Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Sep 19, 2017·0 cites·19 claims
- 2331US9957254B2Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted May 1, 2018·0 cites·17 claims
- 2429US2013197016A1Dosing regimes for the treatment of ocular vascular diseaseBRIGELL MITCHELL·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →